相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Mitochondrial disorders of the OXPHOS system
Erika Fernandez-Vizarra et al.
FEBS LETTERS (2021)
Poly(ADP-ribose) polymerase-1 inhibitor ameliorates dextran sulfate sodium-induced colitis in mice by regulating the balance of Th17/Treg cells and inhibiting the NF-κB signaling pathway
Shuai Peng et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2021)
Pharmacological inhibition of GLUT1 as a new immunotherapeutic approach after myocardial infarction
Ziyi Chen et al.
BIOCHEMICAL PHARMACOLOGY (2021)
Citrobacter rodentium induces rapid and unique metabolic and inflammatory responses in mice suffering from severe disease
Danielle Carson et al.
CELLULAR MICROBIOLOGY (2020)
PARPs and ADP-ribosylation in RNA biology: from RNA expression and processing to protein translation and proteostasis
Dae-Seok Kim et al.
GENES & DEVELOPMENT (2020)
Multifaceted Role of PARP-1 in DNA Repair and Inflammation: Pathological and Therapeutic Implications in Cancer and Non-Cancer Diseases
Simonetta Pazzaglia et al.
CELLS (2020)
Insights into the functional aspects of poly(ADP-ribose) polymerase-1 (PARP-1) in mitochondrial homeostasis in Dictyostelium discoideum
Ashlesha Kadam et al.
BIOLOGY OF THE CELL (2020)
Thermodynamic efficiency, reversibility, and degree of coupling in energy conservation by the mitochondrial respiratory chain
Marten Wikstrom et al.
COMMUNICATIONS BIOLOGY (2020)
ADP-ribosylation: from molecular mechanisms to human disease
Nicolas C. Hoch et al.
GENETICS AND MOLECULAR BIOLOGY (2020)
Diagnostic and Clinical Significance of Serum Levels of D-Lactate and Diamine Oxidase in Patients with Crohn's Disease
Jierui Cai et al.
GASTROENTEROLOGY RESEARCH AND PRACTICE (2019)
PARP inhibition induces Akt-mediated cytoprotective effects through the formation of a mitochondria-targeted phospho-ATM-NEMO-Akt-mTOR signalosome
Antal Tapodi et al.
BIOCHEMICAL PHARMACOLOGY (2019)
Anti-Inflammatory and Antioxidant Properties of Dehydrated Potato-Derived Bioactive Compounds in Intestinal Cells
Manuela Giovanna Basilicata et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
NAD metabolism fuels human and mouse intestinal inflammation
Romana R. Gerner et al.
GUT (2018)
Dysbiosis-Associated Change in Host Metabolism Generates Lactate to Support Salmonella Growth
Caroline C. Gillis et al.
CELL HOST & MICROBE (2018)
Mitochondrial function - gatekeeper of intestinal epithelial cell homeostasis
Eva Rath et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2018)
Intestinal barriers protect against disease
Sandra Citi
SCIENCE (2018)
Microbiota dysbiosis and barrier dysfunction in inflammatory bowel disease and colorectal cancers: exploring a common ground hypothesis
Linda Chia-Hui Yu
JOURNAL OF BIOMEDICAL SCIENCE (2018)
Opportunities for the repurposing of PARP inhibitors for the therapy of non-oncological diseases
Nathan A. Berger et al.
BRITISH JOURNAL OF PHARMACOLOGY (2018)
Reduced mitochondrial activity in colonocytes facilitates AMPKα2-dependent inflammation
Sandra Heller et al.
FASEB JOURNAL (2017)
Diagnostic Value of Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio in Crohn's Disease
Jue-Rong Feng et al.
GASTROENTEROLOGY RESEARCH AND PRACTICE (2017)
Application of the Onodera prognostic nutrition index and neutrophil-to-lymphocyte ratio in risk evaluation of postoperative complications in Crohn's disease
Wei-Ming Kang et al.
SCIENTIFIC REPORTS (2017)
Metabonomics uncovers a reversible proatherogenic lipid profile during infliximab therapy of inflammatory bowel disease
Jacob Tveiten Bjerrum et al.
BMC MEDICINE (2017)
The PARP Inhibitor AZD2461 Provides Insights into the Role of PARP3 Inhibition for Both Synthetic Lethality and Tolerability with Chemotherapy in Preclinical Models
Lenka Oplustil O'Connor et al.
CANCER RESEARCH (2016)
The PARP family: insights into functional aspects of poly (ADP-ribose) polymerase-1 in cell growth and survival
T. Jubin et al.
CELL PROLIFERATION (2016)
Gut microbiome-derived metabolites modulate intestinal epithelial cell damage and mitigate graft-versus-host disease
Nathan D. Mathewson et al.
NATURE IMMUNOLOGY (2016)
High Concentrations of H2O2 Make Aerobic Glycolysis Energetically More Favorable for Cellular
Hamid R. Molavian et al.
FRONTIERS IN PHYSIOLOGY (2016)
The TNBS-induced colitis animal model: An overview
Efstathios Antoniou et al.
ANNALS OF MEDICINE AND SURGERY (2016)
Metabolic reprogramming in macrophages and dendritic cells in innate immunity
Beth Kelly et al.
CELL RESEARCH (2015)
The global burden of IBD: from 2015 to 2025
Gilaad G. Kaplan
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2015)
Poly(ADP-ribose) polymerase-dependent energy depletion occurs through inhibition of glycolysis
Shaida A. Andrabi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Mitochondrial Gene Polymorphisms That Protect Mice From Colitis
Florian Baer et al.
GASTROENTEROLOGY (2013)
Neutrophil-Lymphocyte Ratio as a Predictor of Disease Severity in Ulcerative Colitis
Mehmet Celikbilek et al.
JOURNAL OF CLINICAL LABORATORY ANALYSIS (2013)
Mitochondrial electron transport chain complex dysfunction in the colonic mucosa in ulcerative colitis
Srikanth Santhanam et al.
INFLAMMATORY BOWEL DISEASES (2012)
Intestinal barrier function in health and gastrointestinal disease
M. Camilleri et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2012)
Glutamine Treatment Attenuates Endoplasmic Reticulum Stress and Apoptosis in TNBS-Induced Colitis
Irene Crespo et al.
PLOS ONE (2012)
The Microbiome and Butyrate Regulate Energy Metabolism and Autophagy in the Mammalian Colon
Dallas R. Donohoe et al.
CELL METABOLISM (2011)
Proinflammatory Cytokines in the Pathogenesis of Inflammatory Bowel Diseases
Warren Strober et al.
GASTROENTEROLOGY (2011)
Seroreactivity Against Glycolytic Enzymes in Inflammatory Bowel Disease
Nathalie Vermeulen et al.
INFLAMMATORY BOWEL DISEASES (2011)
The Atypical Cannabinoid O-1602 Protects Against Experimental Colitis and Inhibits Neutrophil Recruitment
Rudolf Schicho et al.
INFLAMMATORY BOWEL DISEASES (2011)
Inflammatory Bowel Disease
Arthur Kaser et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 28 (2010)
Mitochondrial Dysfunction, Persistent Oxidative Damage, and Catalase Inhibition in Immune Cells of Naive and Treated Crohn's Disease
Belen Beltran et al.
INFLAMMATORY BOWEL DISEASES (2010)
Review article: the role of butyrate on colonic function
H. M. Hamer et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2008)
PARP inhibition reduces acute colonic inflammation in rats
Susana Sanchez-Fidalgo et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2007)
Effects of butyrate on intestinal barrier function in a Caco-2 cell monolayer model of intestinal barrier
Luying Peng et al.
PEDIATRIC RESEARCH (2007)
Treatment with PARP-1 inhibitors, GPI 15427 or GPI 16539, ameliorates intestinal damage in rat models of colitis and shock
R Di Paola et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2005)
Activator protein-1 signalling pathway and apoptosis are modulated by poly(ADP-ribose) polymerase-1 in experimental colitis
B Zingarelli et al.
IMMUNOLOGY (2004)
Inhibitors of poly (ADP-ribose) polymerase modulate signal transduction pathways in colitis
B Zingarelli et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2003)
Augmented increase in tight junction permeability by luminal stimuli in the non-inflamed ileum of Crohn's disease
JD Soderholm et al.
GUT (2002)
Protective activity of butyrate on hydrogen peroxide-induced DNA damage in isolated human colonocytes and HT29 tumour cells
P Rosignoli et al.
CARCINOGENESIS (2001)
Effect of poly(ADP-ribose) polymerase inhibitors on the ischemia-reperfusion-induced oxidative cell damage and mitochondrial metabolism in Langendorff heart perfusion system
R Halmosi et al.
MOLECULAR PHARMACOLOGY (2001)
Inhibition of poly( ADP-ribose) polymerase attenuates inflammation in a model of chronic colitis
HB Jijon et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2000)
分享论文
